Molecular alterations associated with liver metastases development in colorectal cancer patients
about
Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature ReviewSingle Nucleotide Polymorphisms as Prognostic and Predictive Factors of Adjuvant Chemotherapy in Colorectal Cancer of Stages I and IIThe CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastasesMethylation changes in the TFAP2E promoter region are associated with BRAF mutation and poorer overall & disease free survival in colorectal cancer.Tracking the Correlation Between CpG Island Methylator Phenotype and Other Molecular Features and Clinicopathological Features in Human Colorectal Cancers: A Systematic Review and Meta-Analysis.The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus.Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial.The tumour biology of synchronous and metachronous colorectal liver metastases: a systematic review.Invited review DNA copy number changes as diagnostic tools for lung cancer.Molecular biomarkers in colorectal carcinoma.Management of patients with colorectal liver metastasis in eleven questions and answers.Chromosome 20q Amplification Defines a Subtype of Microsatellite Stable, Left-Sided Colon Cancers with Wild-type RAS/RAF and Better Overall Survival.Multiple genes identified as targets for 20q13.12-13.33 gain contributing to unfavorable clinical outcomes in patients with hepatocellular carcinoma.PIK3CA mutation and methylation influences the outcome of colorectal cancerEvolving Therapeutic Strategies to Exploit Chromosome Instability in Cancer.
P2860
Q24289005-899B8B5B-97F9-4D01-AFF2-DACFCDEE2D37Q26765344-8AD8D9BC-DD0F-47C0-8C0B-47E74243570EQ33630343-F95581EB-6836-47A3-BCB2-E0A59E76DF23Q35745033-601B2447-06E3-4F81-A839-50F411B6526CQ35952149-3C9FBD3C-F32A-468F-88AF-E053F94FD524Q36349575-FF65C39A-0CAB-4ED9-BA14-B4DC2DC94E58Q37360360-61C094A3-5127-423C-89AA-782A53B5EA78Q38062470-FA18A5B7-2EB8-48C0-AA8B-A6545E3DDC0DQ38159832-AD9405A6-A60B-406B-B5C1-E7304D424A2DQ38559669-6766B9E1-57BE-4C7D-BEFE-26A2BFB48749Q38811107-611A0334-789D-440A-9B9A-AF82CFA4EF2BQ38968819-858A75C5-8EB1-4D20-868A-1B8C0D964C40Q41676450-BA44686C-69BD-4B61-8170-163061EE5FE2Q41850443-EF705DFB-04DB-4E85-8983-79DE70FB43F6Q47119995-1D493610-EDA2-423D-A79C-9297D41B4A00
P2860
Molecular alterations associated with liver metastases development in colorectal cancer patients
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Molecular alterations associat ...... in colorectal cancer patients
@ast
Molecular alterations associat ...... in colorectal cancer patients
@en
type
label
Molecular alterations associat ...... in colorectal cancer patients
@ast
Molecular alterations associat ...... in colorectal cancer patients
@en
prefLabel
Molecular alterations associat ...... in colorectal cancer patients
@ast
Molecular alterations associat ...... in colorectal cancer patients
@en
P2093
P2860
P356
P1476
Molecular alterations associat ...... in colorectal cancer patients
@en
P2093
G-J Liefers
I Mikolajewska-Hanclich
K A de Groot
L J van 't Veer
M-L F van Velthuysen
R A E M Tollenaar
P2860
P2888
P304
P356
10.1038/BJC.2011.184
P407
P577
2011-06-14T00:00:00Z
P5875
P6179
1024121488